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Abstract  
Cardiorespiratory fitness (CRF) is a modifiable risk factor for cardiovascular disease and premature 
mortality. CRF levels and moderators among people living with HIV (PLWH) are unknown. The aim of 
the current meta-analysis was to (1) determine mean CRF in PLWH and compare levels with age- and 
gender-matched healthy controls (HCs), (2) explore moderators of CRF,3and (4) explore moderators 
of CRF outcomes following physical activity (PA) interventions. Major electronic databases were 
searched systematically for articles reporting CRF expressed as maximum or peak oxygen uptake 
(ml/min/kg) in PLWH. A random effects meta-analysis calculating the pooled mean CRF including 
subgroup- and meta-regression analyses was undertaken. Across 21 eligible studies, the CRF level 
was 26.4 ml/kg/min (95%CI=24.6 to 28.1) (n=1,010; mean age =41years). There were insufficient data 
to compare CRF levels with HCs. A higher body mass index (β=-0.99, 95%CI=-1.93 to -0.06, P=0.04), 
older age (β=-0.31, 95%CI=-0.58 to -0.04, P=0.02) and the presence of lipodystrophy (β=-4.63, 
95%CI=-7.88 to -1.39, P=0.005) were significant moderators of lower CRF levels. Higher CD4+ counts 
(β=0.004, 95%CI=0.0007 to 0.007, P=0.016), supervised interventions (P<0.001) and interventions 
with a lower frequency of weekly sessions (2 or 3 versus 4 times) (P<0.001) predicted a better CRF-
outcome following PA. CRF levels of PLWH are among the lowest in comparison to other vulnerable 
populations. More research on the most optimal physical activity intervention characteristics is 
needed. 
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Introduction 
People living with HIV (PLWH) have higher levels of morbidity and mortality than the general 
population (Farahani et al., 2016). The non-AIDS related mortality rates are largely attributable to 
cardiovascular disease (Farahani et al., 2016). Current hypotheses link the increased incidence of 
these comorbidities to side-effects of antiviral therapy (Dillon et al., 2013; El-Sadr, 2007), HIV-related 
chronic inflammation (Hearps et al., 2014) and modifiable lifestyle factors, such as increased tobacco 
use (Lifson and Lando, 2012) and decreased physical activity (Schuelter-Trevisol et al., 2012). There 
is evidence in PLWH that participation in physical activity might reduce cardio-metabolic risk factors 
and improve quality of life (Fillipas et al., 2010; Gomes-Neto et al., 2013; Gomes Neto et al., 2013; 
Leach et al., 2015; Neto et al., 2015; O'Brien et al., 2008). In the general population, there is robust 
evidence demonstrating that low cardiorespiratory fitness (CRF, the ability of the circulatory and 
respiratory systems to supply oxygen to working muscles during sustained physical activity) is a strong 
predictor for CVD [relative risk (RR)=1.56; 95% confidence interval (CI)=1.39-1.75; p<0.001] and all-
cause mortality (RR=1.70; 95%CI=1.51-1.92; P<0.001) (Kodama et al., 2009). Exercise interventions 
aiming to improve CRF should therefore be a key component of preventing and treating CVD and 
reducing associated mortality (Barry et al., 2014).  
A recent meta-analysis (O'Brien et al., 2016) into the effectiveness of aerobic exercise for 
PLWH showed a significant improvement in maximum oxygen uptake (VO2max), which is the gold-
standard for assessing CRF, of 2.63 mL/kg/min following aerobic exercise interventions compared 
with control conditions. These findings clearly highlight that improving CRF is a feasible and effective 
strategy for reducing cardio-metabolic risk among PLWH. Despite the clinical significance of 
measuring CRF in PLWH, it remains unclear exactly what CRF levels are, and what moderates CRF 
levels in PLWH.  Moreover, it remains unclear if PLWH have different CRF levels versus age- and 
gender matched controls.  Pooled analyses exploring subgroup differences in CRF among PLWH are 
highly relevant as they enable risk stratification. Pooling data also allows for more thorough 
investigation of the effect of demographic variables (e.g., age and gender), clinical variables (e.g., 
CD4+ count), assessment variables (e.g., maximal versus submaximal and running versus cycling) 
and treatment variables (antiviral exposure or not) on CRF levels. Finally, whilst a previous meta-
analysis (O'Brien et al., 2016) showed that physical activity interventions can improve CRF, no meta-
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regression analyses has been conducted to investigate moderators which might influence this and 
inform the rehabilitation of PLWH.  
In order to address these current gaps in the literature, we conducted a meta-analysis with the 
following aims: (1) investigate the mean pooled CRF level in PLWH and compare CRF levels where 
possible with age- and gender-matched healthy controls, (2) explore moderators of CRF levels in 
PLWH, and (3) explore moderators of CRF outcomes following physical activity interventions.   
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Methods  
This systematic review adhered to the PRISMA statement (Moher et al., 2009). 
 
Search procedure 
Two researchers (DV and BS) searched PubMed, Embase and CINAHL from database inception to 
May 15, 2016. Key words used were “cardiorespiratory” OR “aerobic” AND “HIV” OR “AIDS” in the 
title, abstract or index term fields. Manual searches were also conducted using the reference lists from 
recovered articles.   
 
Eligibility criteria 
Inclusion criteria were: (a) inclusion of adult participants with a diagnosis of HIV or AIDS, (b) 
measurement of CRF (mean ± standard deviation) expressed as maximal oxygen uptake, VO2max or 
VO2peak (ml/kg/min) and assessed with a maximal exercise test or estimated with a sub-maximal 
exercise test, (c) interventional (randomized controlled trials, clinical controlled trials, one-arm pre-test 
post-test) and observational (prospective or cross sectional) studies conducted in any setting 
(inpatients, outpatients or community patients) with or without a healthy control group. All physical 
activity intervention studies were included. Physical activity was defined in accordance with Caspersen 
et al.(Caspersen et al., 1985) as any interventions that use bodily movement produced by skeletal 
muscles and which requires energy expenditure. Exercise is defined as physical activity interventions 
that were planned, structured, repetitive and purposive, in the sense that improvement or maintenance 
of physical fitness was an objective (Caspersen et al., 1985). No additional exclusion criteria were 
applied. 
 
Study selection 
After the removal of duplicates, two reviewers (DV and BS) screened titles and abstracts of all 
potentially eligible articles. Both authors applied eligibility criteria, and a list of full text articles was 
developed. Two reviewers (DV and BS) then applied eligibility criteria and a final list of included 
articles was reached through consensus. In case of overlap the most recent study was included. 
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Data extraction 
Data extracted for exploring moderators of CRF included assessment variables (maximal versus 
submaximal and running versus cycling), geographical region (North-America versus South-America 
versus Europe versus Africa versus Asia versus Oceania), setting (inpatients versus outpatients 
versus community patients), participants characteristics including mean age (years), % male, % 
Caucasian, mean illness duration (years), mean antiviral treatment duration (months), mean body 
mass index, mean lean body mass loss (kg), mean maximal or peak oxygen uptake (ml/min/kg), mean 
CD4 count (cells/mm³), mean HIV viral load (log
10
 copies/mL), with or without lipodystropy, with or 
without opportunistic infections, % with diabetes, % smoking, % on antiviral therapy.  If age- and 
gender matched healthy control data were available, in addition to the primary outcome, age and % 
male of the healthy control groups were collected. For the intervention analyses, data extracted 
included duration (number of weeks), frequency (times per week), intensity (low versus moderate 
versus high following the American College of Sports Medicine criteria (2009)), and type (aerobic 
exercise only vs mixed) of the physical activity intervention, whether the intervention was supervised 
or not and qualified versus non-qualified providers. Providers of physical activity interventions were 
considered experts when they had at a minimum a bachelor-level degree in physical therapy, exercise 
physiology or a similar qualification that included education in physical activity prescription and 
assessment. 
 
Methodological study appraisal  
Two authors (DV and BS) independently completed methodological quality assessment of included 
articles using the Newcastle–Ottawa Scale (NOS) (Wells et al., 2000). If any disagreement arose, a 
third author (JM) was available for mediation. The NOS provides an assessment of the methodological 
quality of non-randomised trials, and its content validity and reliability have been established (Wells et 
al., 2000). Included studies are judged on 9 items across 3 key areas: selection of the participants, 
comparability of the participants, and outcomes. Each study receives an overall score for 
methodological quality of up to 9 points (one for each item) with higher scores indicating better quality. 
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Statistical analyses 
Random-effects meta-analyses were conducted using Comprehensive Meta-Analysis software 
(Version 3, Biostat, Englewood, New Jersey). First, we pooled the mean CRF level among PLWH and 
where possible compared this to healthy controls (aim 1). Second, we compared baseline CRF levels 
between geographical regions (North-America versus South-America versus Europe versus Africa 
versus Asia versus Oceania), study settings (inpatients versus outpatients versus community 
settings), assessment variables (maximal versus submaximal and running versus cycling) and clinical 
variables (with versus without lipodystrophy and with versus without opportunistic infections)  and 
conducted meta-regression analyses according to age (year), gender (% male), ethnicity (% 
Caucasian), illness duration (years), antiviral treatment duration (months), mean body mass index, 
lean body mass loss (kg), mean CD4 count (cells/mm³), mean HIV viral load (log
10
 copies/mL), % with 
diabetes, % smoking, and % on antiviral therapy (aim 2).  We used the Hedges’ g statistic and 
standard mean differences (SMD) and their 95% confidence intervals (CIs) for calculating the 
estimates of the physical activity interventions effects on CRF levels. Where sufficient data was 
available, exploratory meta-regression analyses were undertaken to investigate the influence on 
physical activity outcomes of mean age (years), gender (% male), ethnicity (% Caucasian), illness 
duration (years), mean body mass index, mean CD4 count (cells/mm³), mean HIV viral load (log
10
 
copies/mL), % on antiviral therapy, and duration (number of weeks), frequency (times per week), of 
the physical activity intervention. We also explored whether the intervention effect differed according 
to different intensity levels (low versus moderate versus high), type (aerobic exercise only vs mixed), 
whether or not the intervention was supervised or not and whether or not providers were qualified or 
not (aim 2).  Finally, we explored changes in CRF following physical activity interventions in PLWH 
calculating Hedges’g and the mean CRF change (aim 3). Statistical heterogeneity was assessed using 
the I² statistic. Publication bias was assessed with the Begg and Mazumdar (1994) test (Begg and 
Mazumdar, 1994). For all analyses we calculated the trim and fill adjusted analysis (Duval and 
Tweedie, 2000) to remove the most extreme small studies from the positive side of the funnel plot, and 
recalculated the effect size at each iteration, until the funnel plot was symmetric about the (new) effect 
size. 
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Results 
Search results and flow of studies through the review 
A total of 1,409 records were identified. After screening titles and application of the eligibility criteria, 
21 studies(Baigis et al., 2002; Cade et al., 2003; Cade et al., 2013; Cutrono et al., 2015; Dolan et al., 
2006; Ezema et al., 2014; Hand et al., 2008; Jaggers et al., 2014; MacArthur et al., 1993; Mangona et 
al., 2015; Mapstone et al., 2014; Mutimura et al., 2008; Neto et al., 2016; Oursler et al., 2009; Perna et 
al., 1999; Ramírez-Marrero et al., 2014; Raso et al., 2013; Smith et al., 2001; Sullivan et al., 2014; 
Terry et al., 2006; Thoni et al., 2002) were eligible for inclusion in the meta-analysis. Figure 1 presents 
the flow of studies through the review process. 
Figure 1 here 
 
Characteristics of included studies 
Across the 21 studies, the final data set included 1,010 PLWH (N CRF values = 36). There were 14 
interventional studies (N CRF values = 26) of which 3 one-arm pre- and post-test studies and 11 RCTs 
and 7 cross-sectional studies (N CRF values = 10). Five CRF values were assessed with maximal 
(n=31) and sub-maximal (n=5) exercise tests. Nine exercise tests were performed on a cycle 
ergometer and 27 on a treadmill. When looking at the settings in which the exercise tests took place, 
four CRF assessments were conducted among inpatients, one in outpatients and 12 in community 
patients. Other tests were performed in mixed or unknown settings. Twenty-five CRF values were 
assessed in North-American PLWH, 5 in South-American (all in Brazil) and 5 in African patients. Only 
one study was conducted in Europe (France). Among available studies, the mean age ranged from 32 
to 58.9 years (N=36), the body mass index from 22.8 to 31 kg/m
2
 (N=26) and years living with HIV 
infection from 4 to 17.6 years (N=12). The gender distribution was available for 34 CRF levels; 621 of 
977 (63.6%) were male. The percentage of people from Caucasian ethnicity ranged from 0% to 93% 
(N=19). The presence of diabetes (N=5) ranged from 0 to 35.1%. The CD4+ count ranged from 104 to 
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663 cells/mm³ (N=28), the viral load from 2.3 to 4.4 log 10 copies/mL (N=6). There were no data on 
mean lean body mass loss and three studies reported on the mean antiviral treatment duration which 
ranged from 63 weeks to 45.2 months (Cade et al., 2003; Terry et al., 2006; Mutimuura et al., 2008). 
Details for all studies are provided in Table 1. 
Table 1 here 
Details for the interventional studies are provided in Table 2. In total 15 studies (n=369; mean age 
range=36-48 years) were included. Fourteen physical activity interventions were supervised 
throughout the intervention period. A qualified instructor was used in 6 of the identified studies. The 
duration of the intervention ranged from 6 to 26 weeks, the frequency of sessions from 2 to 4 times per 
week, the duration (time) of sessions from 20 to 120 min. In 9 interventions the intensity was 
increased up to vigorous levels. Eight interventions investigated aerobic exercise only while 7 were 
combined with resistance training. 
Table 2 here 
 
Methodological quality of included studies 
The NOS score across the studies ranged from 3 to 8 with a mean of 5.8 (SD=2.2). Summary scores 
are presented in Tables 1. 
 
Aim 1: cardiorespiratory fitness in people living with HIV versus controls 
Across the 21 studies (including 36 CRF values) (n=1,010; mean age at study level= 41years), the 
pooled mean predicted VO2 max or VO2 peak was 27.4 ml/kg/min (95%CI = 25.8 to 29.0; I²=99.6%; 
Kendall’s tau=0.09, p=0.46; Egger=-5.1, p=0.15). Although there was no indication of publication bias, 
the trim-and-fill adjusted pooled mean predicted VO2 max or VO2 peak was 26.4 ml/kg/min (95%CI = 
24.6 to 28.1) (N studies adjusted=5). There were insufficient data to compare differences in CRF 
levels between PLWH and age- and gender matched healthy controls. 
 
 
Aim 2: Moderators of cardiorespiratory fitness in people living with HIV  
Full details of the subgroup analyses of CRF levels are summarized in table 3. Higher CRF levels 
were found in maximal versus submaximal exercise tests (P<0.001), in treadmill versus cycle 
ergometer tests (P=0.028) and in people without (versus with) lipodystrophy (P<0.001).  
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When comparing geographical regions with each other we did find higher CRF levels in South-
America versus Africa (z-value=8.2, P<0.001) and versus Europe (z-value=7.9, P<0.001). 
Table 3 here 
 
Higher body mass index (β =-0.99, 95%CI = -1.93 to -0.06, P=0.04), older age (β=-0.31, 95%CI = -
0.58 to -0.04, P=0.02) and the presence of lipodystrophy (β=-4.63, 95%CI = -7.88 to -1.39, P=0.005) 
were significant moderators of lower CRF levels. Full details of all meta-regression analyses of CRF 
levels are summarized in table 4. 
Table 4 here 
 
Aim 3: Cardiorespiratory fitness outcomes and its moderators in people living with HIV following 
physical activity 
The mean improvement in CRF following physical activity interventions was 3.43 ml/min/kg (95% 
CI=1.82 to 5.0). The Hedges’ g was 0.82 (95%CI=0.48 to 1.16, P<0.001), which remained unchanged 
after trim-and-fill adjustment. In the meta-regression analysis only higher levels of CD4+ counts 
predicted a higher SMD. Better CRF outcomes were obtained in physical activity interventions that 
were supervised (versus not-supervised) (P<0.001) and with a lower frequency of weekly sessions (2 
or 3 versus 4 times) (P<0.001). Bèta- and r²-values of the meta-regressions are summarized in Table 
5. 
Table 5 here 
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Discussion 
General findings 
This is the first meta-analysis investigating mean CRF levels in PLWH. Our review identified 21 
studies involving more than 1000 PLWH. The trim and-fill adjusted pooled mean CRF was 26.4 
ml/kg/min (95%CI = 24.6 to 28.1, p<0.001). Although due to limited data available we could not 
compare the CRF levels with age- and gender matched healthy controls, the reported CRF levels are 
among the lowest reported within the clinical literature. For example, a previous meta-analysis (Davy 
Vancampfort et al., 2016) in almost 1000 people with severe mental illness (mean age= 35 years), a 
population known to be at high risk for CVD and premature mortality(D Vancampfort et al., 2016; 
Vancampfort et al., 2015c), the CRF level was 28.7 ml/kg/min (95%CI=27.3 to 30.0 ml/kg/min). This 
meta-analysis is also the first to demonstrate that older age, higher BMI, and the presence of 
lipodystrophy are associated with lower CRF levels among PLWH. Additionally, use of maximal 
(versus sub-maximal) and treadmill (versus cycle ergometer) testing protocols predicted higher CRF 
levels.  
Knowledge of demographic and clinical variables associated with a lower CRF can help 
identify individuals at greatest need for intensive monitoring and intervention to improve CRF. The 
finding that older age was associated with lower CRF levels supports previous research in the general 
population (Parker et al., 2010), while there was also a suggestion that (P=0.06) lower CRF levels are 
found in studies with a lower percentage of male participants. Neither illness duration nor 
immunological parameters influenced CRF levels. However, the presence of lipodystrophy predicted 
lower baseline CRF levels. Previous research in PLWH reported a tendency that lipodystrophy might 
induce mitochondrial dysfunction in the skeletal muscle (Røge et al., 2002). Mitochondria are the main 
energy source for the cells and normal mitochondrial function is needed to permit normal muscle 
function (Zoll et al., 2002). An improvement in CRF in normal subjects is related to both an increased 
skeletal muscle mitochondrial content and an enhanced mitochondrial oxidative capacity (Zoll et al., 
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2002).  Mitochondrial DNA is known to be reduced with the use of antiretroviral drugs such as 
nucleoside reverse transciptase inhibitors, with potential side-effects such as lipodystrophy insulin 
resistance and dislipidemia (Pinti et al., 2006). However, general antiviral exposure (%) was not a 
predictor in our meta-analysis. Moreover, it was previously (Sutinen and Yki-Järvinen, 2007) reported 
as well that there are no differences in the amount of mitochondrial DNA in skeletal muscle of those 
with versus without lipodystrophy. Next to this, PLWH with lipodystrophy are capable of improving 
muscle oxygen uptake and CRF levels, suggesting that the physiological capacity of muscles to 
extract and utilize oxygen is unaltered by lipodystrophy status (Ramírez-Marrero et al., 2014). In 
summary, the integration of cardiovascular, pulmonary, neuromuscular, and metabolic functions 
contributing to changes in CRF in people with versus without lipodystrophy status remains unclear and 
should be a topic of future research. 
We also explored moderators for CRF outcomes following physical activity interventions. The 
current meta-analysis showed that physical activity resulted in a pooled SMD in predicted VO2 max or 
VO2 peak of 3.43 ml/min/kg (95% CI=1.82 to 5.0), in line with findings of a recent meta-analysis 
(O'Brien et al., 2016) in PLWH. Such improvements in CRF are of high clinical relevance. For 
example, among the general population, every 3.5 ml/kg/min incremental increase in VO2 peak is 
associated with 13% and 15% decrements in risk of all-cause mortality and CVD respectively 
(Kodama et al., 2009). Our meta-analysis adds to the current knowledge that higher CD4+ count, 
which is indicative of a better immune response, was associated with higher levels of CRF 
improvement. More research is however needed to clarify associations between immune and CRF 
responses following physical activity. Unfortunately, due to lack of data we could not explore the effect 
of viral load on the CRF response. Our meta-analysis did however show that a better CRF response is 
obtained in response to moderate, as opposed to high intensity exercise. Previous research already 
indicated that moderate intensity physical activity improves the immune function in PLWH (Ezema et 
al., 2014; Garcia et al., 2014), while high-intensity exercise is known to have immunosuppressive 
effects (d'Ettorre et al., 2014). However, data should be interpreted with caution due to the very limited 
data available.  Nonetheless, our data has for the first time provided a comprehensive meta-
regression to identify factors influencing CRF in PLWH and build upon previous meta-analyses which 
have not conducted such analyses.   
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Practical implications 
Improving CRF through physical activity is a feasible, realistic and clinically meaningful outcome in 
PLWH. Special attention should be given to those with lipodystrophy. CRF is a relatively straight-
forward and low-risk measurement in clinical practice. However, consideration of the assessment 
method is needed when interpreting any scores. For example, our data indicate that treadmill tests 
predict higher CRF levels than cycle ergometer tests, an observation also found in the general 
population (Shephard, 1984). Sub-maximal tests, on their turn are underestimating values obtained 
with gold-standard measurements.  
 
Limitations  
Whilst the results are novel, some caution should be attached due to small number of studies included 
in some sub-analyses and due to limitations in reporting of other important variables such as specific 
antiviral treatments, duration of antiviral treatment, mean lean body mass loss and lifestyle factors 
(physical activity, smoking). Future research should focus on these treatment-related and clinical 
parameters. Future research should also further explore in more detail the role of physical activity 
characteristics, i.e. the most optimal frequency, intensity, time and type of physical activity as well as 
motivational considerations. In particular, immunological responses to physical activity interventions 
and association with CRF levels, but also with more distal outcomes such as the risk for 
cardiovascular diseases, diabetes, cancer and premature mortality should be explored in more detail.  
 
Conclusion 
Our meta-analysis demonstrates that PLWH, but in particular those at older age, with a higher BMI 
and with lipodystrophy should be considered as an important high-risk group for low CRF, an 
important predictor of CVD and premature mortality. More research on the most optimal physical 
activity intervention characteristics is needed. 
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Table 1. Characteristics of the included studies 
Author 
 VO2 peak 
/max   
Assess-
ment 
method   
 Cycling / 
running  
 Design  Region  Setting   
Sample 
size  
 Age 
 % 
Male 
 % 
Cauca-
sian  
 BMI  
%  
AV   
Illness 
duration  
 %  
T2DM  
 Lipo-
dystr. 
 % 
current 
smoker  
 Viral 
load  
 CD4+ 
current  
 
NOS 
score 
Cutruno 2016 27.2±8.9 
1 2 
2 
 
1 
 
3 90 
 
48 
 
0 
 
0.10 
 
31  
 
17.6  
 
2 
 
0.36   
3 
Gomes Neto 2016 
[Lipodystrophy]  
31.4±6.1 
2 1 
3 
 
2 0 34 
 
44.9 
 
0.529  
 
23 
 
1   
 
1   490 
7 
Gomes Neto 2016 [No 
Lipodystrophy]  
30.4±7.6 
2 1 
3 
 
2 0 29 
 
40.8 
 
0.552  
 
23.1 
 
1   0   598 
7 
Mangona 2015 32.5±7.1 
2 2 
1 
 
3 0 53 
 
40 
 
0 0 
24.1 
 
1   
 
2   473.6 
8 
Ezema 2014 [exerise 
group]  23.0±2.5 2 2 
1 
3 1 17 40.1 
 
0 28.65 
   
2 
  
516 
8 
Ezema 2014 [control 
group]  24.0±2.5 2 2 
1 
3 1 16 32.5 
 
0 29.01 
   
2 
  
492 
8 
Jaggers 2014 20.1±8.6 2 2 
2 
1 3 63 48 0.492 
    
0.143 2 
   
3 
Ramírez-Marrero 2014  
[Lipodystrophy]  26.8±1.3 2 2 
3 
1 3 32 50.3 0.406 0 29 
  
0.25 1 0.55 
  
7 
Ramírez-Marrero 2014  
[No Lipodystrophy]  32.2±1.5 2 2 
3 
1 3 28 48.1 0.536 0 26.4 
  
0 0 0.19 
  
7 
Sullivan 2014 0.7 29.2±7.6 2 1 
3 
1 0 68 49.2 0.912 
 
26.4 1 16 
 
2 
  
516 
3 
Cade 2013 
[pioglitazone group]  24.3±5.2 2 2 
1 
1 0 12 42 0.75 0.58 30.4 
   
2 
  
638 
7 
Cade 2013 [exercise 
group]  23.6±5.6 2 2 
1 
1 0 8 41 1 0.37 29.9 
   
2 
  
372 
7 
Mapstone 2013 20.3±6.4 2 2 
3 
1 0 37 58.9 0.818 
 
28.4 1 16.8 0.351 2 0.38 
 
663 
2 
Raso 2013 34.2±0.9 2 2 
3 
2 2 39 40.6 1 
 
24.8 0.461 6.1 
 
2 
 
4.4 521 
7 
Oursler 2009 18.4±5.6 2 2 
3 
1 3 43 57.5 1 0.116 
   
0.116 2 0.63 
  
3 
Hand 2008 [male 
experimental group]  31.6±0.4 2 2 
1 
1 3 14 41.2 1 
     
2 
   
8 
Hand 2008 [female 
experimental group]  31.2±0.3 2 2 
1 
1 3 7 41.2 0 
     
2 
   
8 
Hand 2008  
[control group]  29.4±0.3 2 2 
1 
1 3 19 42.4 0.84 0.316 
    
2 
   
8 
Mutimura 2008  
[no exercise group]  23.9±2.9 1 2 
1 
3 1 50 37.5 0.4 
 
24.4 1 
  
1 0.2 
 
348 
8 
Mutimura 2008 
[exercise group]  24.3±3.8 1 2 
1 
3 1 50 37.8 0.4 
 
24 1 
  
1 0.14 
 
353 
8 
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Table 1. Continued. 
Author 
 VO2 peak 
/max   
Assess-
ment 
method   
 Cycling / 
running  
 Design  
Region  Setting   
Sample 
size   Age  % Male 
 % 
Cauca-
sian  BMI  
%  
AV   
Illness 
duration  
 %  
T2DM  
 Lipo-
dystr. 
 % 
current 
smoker  
 Viral 
load  
 CD4+ 
current  
NOS 
 score 
Dolan 2006 [exercise 
group]  16.9±1.0 1 1 
1 
1 3 20 43 0 0.35 29.3 0.85 11 
 
2 0.35 2.3 539 
7 
Dolan 2006 
[control group]  15.3±1.1 1 1 
1 
1 3 20 40 0 0.2 28.6 0.8 9 
 
2 0.55 3 419 
7 
Terry 2006  
[diet and exercise]  32.0±5.0 2 2 
1 
2 0 15 36 0.6 0.87 25 1 6 
 
1 
  
563 
8 
Terry 2006  
[diet]  34.0±7.0 2 2 
1 
2 0 15 39 0.73 0.93 24 1 6 
 
2 
  
435 
8 
Cade 2003 24.6±1.2 2 2 
3 
1 0 15 41.9 0.67 
 
26.9 
 
7 
 
2 0.27 
 
430 
6 
Baigis 2002 [exercise 
group]  30.2±6.4 2 2 
1 
1 3 52 39 0.81 0.33 
    
2 
  
352 
7 
Baigis 2002  
[no exercise group]  32.0±7.1 2 2 
1 
1 3 47 34.5 0.79 0.32 
    
2 
  
365 
7 
Thöni 2002 25.2±1.2 2 1 
3 
 
4 0 17 44.4 0.71 
 
23.5 1 6.7 
 
1 
 
2.1 514 
3 
Smith 2001 [exercise 
group]  34.9±5.7 2 2 
1 
1 0 18 36.6 0.78 
 
27.2 
 
4 
 
2 
 
3.7 328 
8 
Smith 2001  
[control group]  31.0±5.9 2 2 
1 
1 0 29 35.4 0.86 
 
27.6 
 
4.5 
 
2 
 
3.9 357 
8 
Perna 1999 [compliant 
group]  28.7±7.5 2 1 
1 
1 0 11 36.7 0.82 0.357 22.8 
   
2 
  
468 
8 
Perna 1999  
[non-compliant group]  25.4±9.1 2 1 
1 
1 0 7 36.7 0.57 0.357 30.2 
   
2 
  
476 
8 
Perna 1999  
[control group]  28.3±9.6 2 1 
1 
1 0 10 36.7 0.5 0.357 26.9 
   
2 
  
420 
8 
Mac Arthur 1993 
[compliant group]  33.2±3.3 2 2 
2 
1 0 6 38.8 1 
     
2 
  
209 
3 
Mac Arthur 1993 
[somewhat compliant 
group]  29.8±10.0 2 2 
2 
1 0 7 32 1 
     
2 
  
158 
3 
Mac Arthur 1993 [non 
compliant group]  29.7±8.3 2 2 2 1 0 12 35.5 0.83 
     
2 
  
104 
3 
VO2 peak /max= peak / maximal oxygen uptake expressed as ml/min/kg (mean±standard deviation); assessment method: 1=a submaximal exercise test, 2=a maximal exercise test); cycling/running: 1=exercise test on a 
treadmill, 2=exercise test on a cycle ergometer; design: 1=randomized controlled trial,  2=one-arm pre-test post-test study, 3=cross-sectional study; region: 1= North-America, 2=South-America, 3=Africa, 4=Europe; 
setting:0=mixed or unknown, 1=inpatients, 2=outpatients, 3=community patients; BMI=body mass index; % AV= percentage of people on antiviral therapy; illness duration expressed in years;T2DM= type 2 diabetes mellitus; 
lipodystrophy: 0=0%, 1=100%, 2=unknown; Opportunistic infections:0=0%, 1=unknown; viral load expressed in log 10 copies/mL.mean CD4+ count  expressed in cells/mm³; NOS=Newcastle–Ottawa Scale. 
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Table 2. Characteristics of the interventional studies 
 
 Post VO2 
mean  
 Post VO2  
SD  
 Supervision   Providers  
 
Duration 
(weeks)  
 Frequency 
(per week)  
Intensity  
 Time 
(min)  
 Type  
Cutruno 2016 29.0 10.0 1 1 12 4 2 60 2 
Mangona 2015 [formal exercise] 38.1 7.1 1 1 13 3 3 60 2 
Mangona 2015 [playful exercise] 34.8 9.9 1 1 13 3 2 60 1 
Ezema 2011 30.9 4.4 1 1 8 3 2 60 1 
Cade 2013  26.0 7.9 1 0 16 3 3 120 2 
Hand 200 39.9 1.9 1 0 6 2 2 60 2 
Mutimura 2008 24.4 2.9 1 0 26 3 2 90 2 
Dolan 2006  18.4 1.0 1 1 16 3 2 120  2 
Terry 2006  40.0 8.0 1 0 12 3 3 60 2 
Baigis 2002  30.5 6.3 0 0 15 3 3 20 1 
Thöni 2002 27.8 1.5 1 0 16 2 2 45 1 
Smith 2001  33.2 5.9 1 0 12 3 3 30 1 
Perna 1999 [compliant group] 32.2 7.3 1 0 12 3 3 45 1 
Perna 1999 [non-compliant group] 25.5 8.8 1 0 12 3 3 45 1 
Mac Arthur 1993 [compliant group] 41.2 4.9 1 1 24 3 3 40 1 
 
Supervision: 1=yes. 0=no; provider: 1=experts (i.e. minimum a bachelor-level degree in physical therapy. exercise physiology or a similar that included 
education in physical activity prescription and assessment; Intensity (maximal): 1=low. 2=moderate. 3=high; Type: 1=aerobic exercise. 2=mixed. 
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Table 3. Subgroup analyses of cardiorespiratory fitness (expressed as ml/min/kg) in people living with HIV 
Analysis N 
studies 
N participants Meta-analysis 
Point estimate         95%CI 
I² P* 
Subgroup analyses        
 Maximal versus Sub-maximal testing      99.6 <0.001 
- Maximal 31 780 28.4 27.3 29.5   
- Submaximal 5 230 21.4 18.8 23.9   
 Treadmill versus cycle ergometer test      99.6 0.03 
- Treadmill 27 794 28.0 26.8 29.2   
- Cycle ergometer 9 216 25.1 22.8 27.4   
 Geographical region      99.6 0.09 
- North-America 25 675 26.9 25.0 28.8   
- South-America 5 132 32.4 28.1 36.7   
- Africa 5 186 25.5 21.3 29.7   
- Europe 1 17 25.2 15.9 34.4   
 Setting      99.6 0.07 
- Inpatients 4 133 23.8 19.2 28.4   
- Outpatients 1 39 34.2 24.9 43.5   
- Community patients 12 435 25.9 23.2 28.6   
 Design      99.6 0.53 
- Interventional studies (baseline) 27 690 27.7 25.8 29.7   
- Observational studies 9 320 26.5 23.2 29.8   
 Presence of lipodystrophy      99.6 <0.001 
- Yes 6 198 27.2 23.3 31.1   
- No 2 57 31.3 24.5 38.1   
*Significant when P<0.05 
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Table 4.  Meta-regressions of moderators of cardiorespiratory fitness (expressed as ml/min/kg) in people living with HIV 
 
Moderator Number of 
comparisons 
β 95% CI P-value* R² 
Mean age (years) 36 -0.31 -0.58 -0.04 0.02 0.02 
Gender (% male) 34 0.05 -0.002 0.09 0.06 0.04 
Illness duration (years) 26 -0.59 -1.59 0.30 0.19 0.34 
Body mass index (kg/m²) 12 -0.99 -1.93 -0.06 0.04 0.34 
Ethnicity (% Caucasian) 19 0.06 -0.08 0.19 0.41 0 
Smoking (%) 10 -0.16 -0.41 0.09 0.21 0 
Antiviral exposure (%) 13 -0.006 -0.30 0.29 0.97 0.23 
CD4+ count (mean cells/mm³) 28 -0.01 -0.04 0.01 0.37 0 
HIV load (mean log
10
 copies /mm³ 6 6.82 -0.35 13.99 0.06 0.46 
Diabetes (%) 5 -0.20 -0.68 0.27 0.40 0 
Lipodystrophy (presence) 8 -4.63 -7.88 -1.39 0.005 0.71 
*Significant when P<0.05.  
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Table 5. Meta-regression and subgroup analyses of moderators of the cardiorespiratory fitness outcome following exercise in people with HIV 
 Number of 
comparisons 
β 95% CI r
2
 p-value* 
Mean age (years) 15 0.08 -0.05  0.20 0 0.25 
Gender (% male) 14 0.19 -0.81 1.18 0 0.71 
Illness duration (years) 5 -0.01 -0.21 0.18 0 0.87 
Body mass index (kg/m²) 10 -0.04 -0.20 0.12 0 0.64 
Ethnicity (% Caucasian) 10 0.04 -1.33 1.41 0 0.95 
CD4+ count (mean cells/mm³) 11 0.004 0.0007 0.007 0.53 0.016 
Physical activity intervention time (min) 15 0.004 -0.009 0.016 0 0.56 
Physical activity duration (weeks) 15 -0.07 -0.14 0.01 0 0.11 
 Number of 
comparisons 
Hedges’ g 95% CI I
2
 (%) p-value* 
Physical activity intervention intensity     92.0 0.069 
- Moderate 6 1.45 0.88 2.02 95.8 <0.001 
- Moderate to high 9 0.43 -0.02 0.88 79.9 0.062 
Physical activity frequency     92.0 <0.001 
- 2 times per week 2 2.80 1.82 3.78 92.8 <0.001 
- 3 times per week 12 0.61 0.25 0.96 88.4 <0.001 
- 4 times per week 1 0.19 -0.95 1.33 0 0.75 
Supervision the entire period     92.0 0.033 
- Yes 14 0.90 0.51 1.28 92.2 <0.001 
- No 1 0.05 -1.29 1.39 0 0.94 
Qualification of the provider     92.0 0.44 
- Qualified 6 1.01 0.43 1.60 91.4 <0.001 
- Not qualified / unknown 9 0.72 0.24 1.19 92.8 0.003 
Setting     92.0 0.47 
- Inpatients 2 0.91 -0.17 1.98 96.7 0.10 
- Community patients 4 1.23 0.45 2.00 96.4 0.002 
*Significant when p<0.05. °Providers of physical activity interventions were considered experts when they had at a minimum a bachelor-level degree in 
physical therapy, exercise physiology or a similar qualification that included education in physical activity prescription and assessment. 
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Highlights 
 The treatment of people living with HIV should include a focus on cardiorespiratory fitness. 
 Special attention should be given to those with lipodystrophy. 
 A better cardiorespiratory fitness response is obtained following moderate as opposed to high 
intensity exercise. 
 More research on the most optimal physical activity prescription for people living with HIV is 
needed. 
